Sinopharm Group Co. Ltd. (SHTDF)
Sinopharm Statistics
Share Statistics
Sinopharm has 3.12B shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 3.12B |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.11B |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 6.08 and the forward PE ratio is null. Sinopharm's PEG ratio is 0.98.
| PE Ratio | 6.08 |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| Forward PS | n/a |
| PB Ratio | 0.74 |
| P/FCF Ratio | 3.71 |
| PEG Ratio | 0.98 |
Enterprise Valuation
Sinopharm has an Enterprise Value (EV) of 65.05B.
| EV / Sales | 0.11 |
| EV / EBITDA | 2.42 |
| EV / EBIT | 3.79 |
| EV / FCF | 4.38 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.39 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 2.74 |
| Debt / FCF | 4.97 |
| Interest Coverage | 7.55 |
Financial Efficiency
Return on Equity is 12.14% and Return on Invested Capital is 8.65%.
| Return on Equity | 12.14% |
| Return on Assets | 2.36% |
| Return on Invested Capital | 8.65% |
| Revenue Per Employee | $5.51M |
| Profits Per Employee | $83.66K |
| Employee Count | 108,217 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 9.13 |
Taxes
| Income Tax | 4.5B |
| Effective Tax Rate | 23.07% |
Stock Price Statistics
The stock price has increased by -25.61% in the last 52 weeks. The beta is 0.63, so Sinopharm's price volatility has been higher than the market average.
| Beta | 0.63 |
| 52-Week Price Change | -25.61% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 2.36 |
| Relative Strength Index (RSI) | 8.79 |
| Average Volume (20 Days) | 103 |
Income Statement
In the last 12 months, Sinopharm had revenue of 596.57B and earned 9.05B in profits. Earnings per share was 2.9.
| Revenue | 596.57B |
| Gross Profit | 48.51B |
| Operating Income | 22.32B |
| Net Income | 9.05B |
| EBITDA | 26.9B |
| EBIT | 22.47B |
| Earnings Per Share (EPS) | 2.9 |
Balance Sheet
The company has 63.81B in cash and 73.78B in debt, giving a net cash position of -9.97B.
| Cash & Cash Equivalents | 63.81B |
| Total Debt | 73.78B |
| Net Cash | -9.97B |
| Retained Earnings | 49.41B |
| Total Assets | 413.07B |
| Working Capital | 96.58B |
Cash Flow
In the last 12 months, operating cash flow was 17.17B and capital expenditures -2.34B, giving a free cash flow of 14.84B.
| Operating Cash Flow | 17.17B |
| Capital Expenditures | -2.34B |
| Free Cash Flow | 14.84B |
| FCF Per Share | 4.76 |
Margins
Gross margin is 8.13%, with operating and profit margins of 3.74% and 1.52%.
| Gross Margin | 8.13% |
| Operating Margin | 3.74% |
| Pretax Margin | 3.27% |
| Profit Margin | 1.52% |
| EBITDA Margin | 4.51% |
| EBIT Margin | 3.74% |
| FCF Margin | 2.49% |
Dividends & Yields
SHTDF pays an annual dividend of $0.22, which amounts to a dividend yield of 4.32%.
| Dividend Per Share | $0.22 |
| Dividend Yield | 4.32% |
| Dividend Growth (YoY) | -24.06% |
| Payout Ratio | 69.45% |
| Earnings Yield | 16.44% |
| FCF Yield | 26.94% |
Analyst Forecast
Currently there are no analyst rating for SHTDF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 7 |